ImClone Investigational Site

Atlanta, Georgia 30342

0 studies enrolling now · 13 studies all time

What they study most

Breast Cancer, Cancer, Carcinoma, Colorectal Cancer, Colorectal Neoplasms, Gastric Cancer, Head and Neck Cancer, Metastatic Pancreatic Cancer, Neuroendocrine Tumors, Non-Small Cell Lung Cancer, Prostate Cancer, Sarcoma, Soft Tissue

Studies at this site

• Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer — Completed
• A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer — Completed
• A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma — Completed
• Study of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer Patients — Completed
• A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Participants With Lung Cancer Who Have Not Received Chemotherapy Before — Completed
• Study of IMC-A12, Alone or in Combination With Cetuximab, in Participants With Recurrent or Metastatic Squamous Cell Carcinoma (MSCC) of the Head and Neck — Completed
• A Study of Olaratumab in Soft Tissue Sarcoma — Completed
• Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes — Completed
• A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate Cancer — Completed
• Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer — Stopped early
• Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer — Completed
• Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer — Completed
• A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer — Completed